A new study recently published in the Journal of the National Cancer Institute showed cervical cancer rates have decreased in states with high HPV vaccine rates.
Cervical cancer incidence has declined close to 30% among women aged 20 to 31 years since the start of the millennium, but certain states have achieved significantly greater reductions. Washington, D.
Figure A shows the age-standardized incidence and mortality of cervical cancer worldwide in 2022. The blue diamond represents the regional rate, the black vertical line represents the country rate, ...
However, the study found significant disparities across individual states — ranging from a 50% decrease in cervical cancer cases in three states and the District of Columbia, to little or no decline ...
Declines in cervical cancer incidence among young U.S. women during the human papillomavirus (HPV) vaccination era vary by geographic region, according to a study published online Feb. 23 in the ...
Cervical cancer incidence is rising, with rural and minoritized populations experiencing worse outcomes due to suboptimal care and screening disparities. Data from 2001-2019 reveal a widening gap in ...
Cervical cancer, considered a “highly preventable” disease, has long been declining in the United States — but it’s now on the rise among women in their 30s and 40s. Rates climbed 1.7 percent among ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results